Federal contractor · GERMANTOWN, MD

HBVTECH, L.L.C

No contract obligations recorded for HBVTECH, L.L.C in FY2026. Since FY2020: $2.5M. Its largest customer was National Institutes of Health ($0).

Obligations · FY2026
$0
New awards
1
Sole-source
—
Single offer
—
UEI
WEXNYHY4EZB5
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 299.9KFY2020
  2. 6.5KFY2021
  3. 1.5MFY2022
  4. 50KFY2023
  5. 606.2KFY2025
  6. 0FY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$00.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. EVALUATING HBVZ10-BASED THERAPIED FOR CCCDNA CLEARANCE: VIROLOGICAL FOUNDATION AND SYNERGISTIC COMBINATIONS$606.2K
    National Institutes of Health· Montgomery County, MD· Research & development· Jul 28, 2025 – Jul 13, 2026· 75N93025C00023

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

HBVTECH, L.L.C received $0 in federal assistance in FY2026, on 1 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2021
$5.8M

Assistance by fiscal year

  1. 579.9KFY2021
  2. 0FY2022
  3. 280KFY2023
  4. 0FY2024
  5. 5MFY2025
  6. 0FY2026

Largest awards

  1. A DEVELOPMENT STRATEGY TO OBTAIN IND APPROVAL OF HBVZ10, A NEW HBV CURE THERAPY CANDIDATE - HBV CCCDNA PERSISTENCE IS THE ROOT CAUSE OF…$258.8K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 27, 2025 – Jun 29, 2026· R34AI194337

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. KEPHERA DIAGNOSTICS LLC$600K−100% in FY2026
    FRAMINGHAM, MA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. VITRUVIAN BIO, LLC$600K
    BALTIMORE, MD · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. BIG EYE DIAGNOSTICS INC$599.6K−100% in FY2026
    SAN DIEGO, CA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.